[1]IGLESIA D,AVCI B,KIRIUKOVA M,et al.Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer:A systematic review and meta-analysis[J].United European Gastroenterol J,2020,8(9):1115-1125.
[2]MIZRAHI JD,SURANA R,VALLE JW,et al.Pancreatic cancer[J].Lancet,2020,395(10242):2008-2020.
[3]REN H,MAI G,LIU Y,et al.Eukaryotic translation initiation factor 3 subunit B is a promoter in the development and progression of pancreatic cancer[J].Front Oncol,2021,11:644156.
[4]VAKIRLIS N,CARVUNIS AR,MCLYSAGHT A.Synteny-based analyses indicate that sequence divergence is not the main source of orphan genes[J].Elife,2020,9:e53500.
[5]PAPAMICHOS SI,MARGARITIS D,KOTSIANIDIS I.Adaptive evolution coupled with retrotransposon exaptation allowed for the generation of a human-protein-specific coding gene that promotes cancer cell proliferation and metastasis in both haematological malignancies and solid tumours:The extraordinary case of MYEOV gene[J].Scientifica (Cairo),2015,2015:984706.
[6]JANSSEN JW,VAANDRAGER JW,HEUSER T,et al.Concurrent activation of a novel putative transforming gene,myeov,and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)[J].Blood,2000,95(8):2691-2698.
[7]LIANG E,LU Y,SHI Y,et al.Correction to:MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity[J].Oncogene,2021,40(9):1755.
[8]WANG J,ZHANG X,YAO H,et al.MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV[J].Hum Cell,2020,33(1):261-271.
[9]FANG L,WU S,ZHU X,et al.MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-beta pathway in NSCLC[J].Oncogene,2019,38(6):896-912.
[10]CHARI ST,SHARMA A,MAITRA A.Early detection of sporadic pancreatic ductal adenocarcinoma:Problems,promise,and prospects[J].Ann Intern Med,2020,172(8):558-559.
[11]徐俊明,曹爽,张欣雪,等.胰腺癌腹腔淋巴结转移相关危险因素分析[J].北京医学,2022,44(04):298-302.
XU JM,CAO S,ZHANG XX,et al.Risk factors of abdominal lymph node metastasis in pancreatic cancer[J].Beijing Medical Journal,2022,44(04):298-302.
[12]CHEN S,SHEN Z,GAO L,et al.TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9[J].Ann Transl Med,2021,9(16):1338.
[13]ASHRAFIZADEH M,MIRZAEI S,HASHEMI F,et al.New insight towards development of paclitaxel and docetaxel resistance in cancer cells:EMT as a novel molecular mechanism and therapeutic possibilities[J].Biomed Pharmacother,2021,141:111824.
[14]周文涛,王单松.胰腺癌中STAT3信号通路作用及其机制的研究进展[J].复旦学报(医学版),2016,43(06):757-762.
ZHOU WT,WANG DS.Advances in the role of STAT3 signaling pathway and mechanism in pancreatic cancer[J].Fudan University Journal of Medical Sciences,2016,43(06):757-762.
[15]PAN T,ZHANG F,LI F,et al.Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL-6/STAT3 signaling pathway[J].Oncology Reports,2020,44(3):1049-1063.